Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AC Immune (ACIU) Tax Provisions: 2017-2025

Historic Tax Provisions for AC Immune (ACIU) over the last 7 years, with Sep 2025 value amounting to $1.1 million.

  • AC Immune's Tax Provisions fell 60.14% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$208,850, marking a year-over-year decrease of 107.46%. This contributed to the annual value of $3,425 for FY2024, which is 69.62% down from last year.
  • As of Q3 2025, AC Immune's Tax Provisions stood at $1.1 million, which was down 43.00% from $1.9 million recorded in Q2 2025.
  • AC Immune's Tax Provisions' 5-year high stood at $5.4 million during Q4 2021, with a 5-year trough of -$2.8 million in Q4 2024.
  • Over the past 3 years, AC Immune's median Tax Provisions value was -$3,243 (recorded in 2023), while the average stood at $234,502.
  • Data for AC Immune's Tax Provisions shows a peak YoY increase of 80,706.92% (in 2024) and a maximum YoY decrease of 72,947.02% (in 2024) over the last 5 years.
  • Quarterly analysis of 5 years shows AC Immune's Tax Provisions stood at $5.4 million in 2021, then crashed by 99.54% to $24,913 in 2022, then declined by 14.02% to $21,420 in 2023, then tumbled by 13,311.33% to -$2.8 million in 2024, then plummeted by 60.14% to $1.1 million in 2025.
  • Its Tax Provisions stands at $1.1 million for Q3 2025, versus $1.9 million for Q2 2025 and -$384,839 for Q1 2025.